Free Carboplatin Calculator

Carboplatin Dosing Using the Calvert Formula

The carboplatin dose calculator described here applies the established Calvert formula to determine the total carboplatin dose (in mg) required for a given chemotherapy regimen. As a precise chemotherapy dose calculator, this tool integrates two critical inputs: the estimated glomerular filtration rate (GFR) and a target area under the curve (AUC) value. The GFR is derived from serum creatinine, age, weight, and sex using the Cockcroft‑Gault equation, which provides a practical estimate of kidney function in everyday oncology practice.

Carboplatin is a platinum‑based agent used to treat several malignancies (e.g., lung, ovarian, and brain cancers). Because approximately 70% of the drug is excreted unchanged by the kidneys within 24 hours, renal function strongly influences the appropriate dose. The Calvert formula linearizes this relationship:

$$\text{Carboplatin dose (mg)} = \text{AUC} \times (\text{GFR} + 25)$$

where:

• AUC is the target area under the plasma concentration‑time curve (expressed in mg·min/mL);
• GFR is the glomerular filtration rate measured in mL/min.

Maximum Recommended Dose

For patients with normal renal function, the GFR input is clinically capped at 125 mL/min to avoid excessive toxicity. Under this cap the equation simplifies to:

$$\text{Maximum carboplatin dose (mg)} = \text{AUC} \times (125 + 25) = \text{AUC} \times 150$$

Thus, the ceiling dose is driven solely by the chosen AUC target.

What Is AUC?

In pharmacokinetics, the area under the curve (AUC) represents the total systemic exposure to the drug over time. It is typically estimated via the trapezoidal rule from serial plasma concentration measurements. For carboplatin, common target AUC values range from 5 to 7 mg·min/mL, depending on the treatment protocol, prior therapy, and the patient’s performance status. Using a carboplatin AUC calculator embedded in this tool, clinicians can quickly test different AUC scenarios and select the most appropriate regimen.

Estimation of GFR: Cockcroft‑Gault Equation

The tool first computes GFR using the Cockcroft‑Gault formula. Two versions are used, one for men and one for women:

• Men:

  $$\text{GFR} = \frac{(140 - \text{age}) \times \text{weight (kg)}}{72 \times \text{serum creatinine (mg/dL)}}$$

• Women:

  $$\text{GFR} = 0.85 \times \text{GFR}_{\text{men}}$$

Example calculation:
For a 50‑year‑old man weighing 78 kg with a serum creatinine of 1.2 mg/dL:

$$\begin{aligned} \text{GFR} &= \frac{(140 - 50) \times 78}{72 \times 1.2} \\ &= \frac{90 \times 78}{86.4} \\ &= 81.25\ \text{mL/min} \end{aligned}$$

Once the GFR is known, the Calvert formula is applied. Using a target AUC of 7 mg·min/mL:

$$\begin{aligned} \text{Dose} &= 7 \times (81.25 + 25) \\ &= 7 \times 106.25 \\ &= 743.8\ \text{mg} \end{aligned}$$

The calculator performs both steps instantaneously, saving time and reducing manual calculation errors.

Special Considerations for Dosing

• Overweight or obese patients (BMI ≥ 25 kg/m²): To avoid under‑ or overdosing, the tool can use an adjusted body weight (AdjBW):

  $$\text{AdjBW (kg)} = \text{IBW} + 0.4 \times (\text{CBW} - \text{IBW})$$

  where IBW is the ideal body weight and CBW is the current body weight.

• Low serum creatinine: When creatinine is very low (e.g., below 0.7 mg/dL), a minimum value of 0.7 mg/dL is often substituted to prevent overestimation of GFR and subsequent underdosing.

• Higher AUC targets ( > 6 mg·min/mL) or uncapped clearance: For these scenarios, reliance on a mathematical formula alone may be insufficient. Direct measurement of creatinine clearance via EDTA clearance or 24‑hour urine collection is recommended to obtain a more reliable GFR estimate.

Important Clinical Reminder

While this carboplatin dose calculator is designed to be accurate and consistent with published guidelines, it is a supplementary tool and does not replace professional medical judgment. All dosing decisions should be made by qualified healthcare providers, taking into account the patient’s full clinical status, treatment history, and institutional protocols.

By integrating the Calvert formula with standard renal function estimates, the calculator offers a quick, reproducible way to verify carboplatin doses and explore “what‑if” scenarios for AUC targets, making it a valuable aid in modern oncology practice.